Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21764582 | 0.79 | LMNA (0.31) | — | |
| SCHEMBL243552 | 0.77 | LMNA (0.40) | — | |
| SCHEMBL553541 | 0.75 | LMNA (0.38) | — | |
| SCHEMBL695544 | 0.75 | LMNA (0.38) | — | |
| SCHEMBL555010 | 0.75 | LMNA (0.38) | — | |
| SCHEMBL21815536 | 0.73 | LMNA (0.33) | — | |
| SCHEMBL571123 | 0.72 | LMNA (0.36) | — | |
| Methylamine SCHEMBL17749558 | 0.72 | FDPS (0.41) | — | |
| SCHEMBL31405507 | 0.71 | HSD17B10 (0.42) | PEPDBTN3A1 | |
| SCHEMBL27728715 | 0.71 | BTN3A1 (0.50) | PEPDBTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168615-B2 | Prodrugs of piperazine and substituted piperidine antiviral agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-05-01 | — | — | US | disclosed |
| EP-1877403-B1 | MONO-LYSINE SALTS OF AZOLE COMPOUNDS | EISAI R&D MAN CO LTD (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-20100210599-A1 | PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210599-A1 | PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS | ZC3HAV1L, CCR5, CCRL2 | PEPD 204/4885BTN3A1 3812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.